Description: Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral spray; Renochlor, a dietary supplement to aid in the restoration of kidney health and kidney function; and Sucanon, an insulin sensitizer that lowers blood sugar by increasing the muscle, fat, and liver's sensitivity to insulin. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and powders. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.
Home Page: www.genixpharm.com
1055 West Hastings Street
Vancouver,
BC
V6E 2E9
Canada
Phone:
604 609 6198
Officers
| Name | Title |
|---|---|
| Mr. Mahmoud S. Aziz | Chairman of the Board & President |
| Mr. Sina Salehi Pirooz | CEO & Director |
| Mr. Wayne Kent Lee CA, CPA | Chief Financial Officer |
| Mr. Kevin James Bottomley | Director of Corporate Development & Independent Director |
| Ms. Monita Franziska Valeska Faris | Company Secretary |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.57 |
| Price-to-Sales TTM: | 657.0877 |
| IPO Date: | |
| Fiscal Year End: | October |
| Full Time Employees: | 0 |